ChiCTR2000035543 版本V1.2 版本创建时间2020/08/13 12:26:25 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000035543 

最近更新日期:

Date of Last Refreshed on:

2020-08-13 12:24:56 

注册时间:

Date of Registration:

2020-08-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于代谢组学技术探究败血症婴儿脂代谢水平和相关机制的研究

Public title:

Study on lipid metabolism level of septic infants and related mechanism based on metabolomics technology

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于代谢组学技术探究败血症婴儿脂代谢水平和相关机制的研究

Scientific title:

Study on lipid metabolism level of septic infants and related mechanism based on metabolomics technology

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

查新祎 

研究负责人:

钱继红 

Applicant:

Xinyi Zha 

Study leader:

Jihong Qian 

申请注册联系人电话:

Applicant telephone:

+86 18817818172

研究负责人电话:

Study leader's telephone:

+86 13651713726

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

18817818172@163.com

研究负责人电子邮件:

Study leader's E-mail:

qianjihong@xinhuamed.com.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市杨浦区控江路1665号

研究负责人通讯地址:

上海市杨浦区控江路1665号

Applicant address:

1665 Kongjiang Road, Yangpu District, Shanghai, China

Study leader's address:

1665 Kongjiang Road, Yangpu District, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海交通大学医学院附属新华医院

Applicant's institution:

Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine

研究负责人所在单位:

上海交通大学医学院附属新华医院

Affiliation of the Leader:

Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

XHEC-C-2020-091-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海交通大学医学院附属新华医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of Xinhua Hospital Affliated to Shanghai Jiaotong University School of Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020-07-30 00:00:00

伦理委员会联系人:

上海交通大学医学院附属新华医院医学伦理委员会

Contact Name of the ethic committee:

Medical Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

伦理委员会联系地址:

上海市杨浦区控江路1665号

Contact Address of the ethic committee:

1665 Kongjiang Road, Yangpu District, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 021 25076143

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海交通大学医学院附属新华医院

Primary sponsor:

Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine

研究实施负责(组长)单位地址:

上海市杨浦区控江路1665号新华医院

Primary sponsor's address:

1665 Kongjiang Road, Yangpu District, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海交通大学医学院附属新华医院

具体地址:

上海市杨浦区控江路1665号

Institution
hospital:

Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine

Address:

1665 Kongjiang Road, Yangpu District

经费或物资来源:

自筹

Source(s) of funding:

self-funding

Target disease:

Neonatal sepsis

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

观察败血症婴儿脂代谢的水平并探究相关机制  

Objectives of Study:

Testing the lipid metabolism levels in septic infants and investigating the related mechanism

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.2月龄以下在新生儿科住院的患儿
2.败血症组:血培养结果阳性或诊断临床败血症的患儿
3.对照组:因新生儿黄疸(排除感染因素)住院的患儿

Inclusion criteria

1.infants <2months;
2.Septic group: infants diagnosed with sepsis;
3.Control group: infants hospitalised because of jaundice(excluding infectious reasons).

排除标准:

明确诊断代谢性疾病的患儿。

Exclusion criteria:

infants diagnosed with metabolic disease

研究实施时间:

Study execute time:

From 2020-08-01 00:00:00 To 2022-07-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-08-01 00:00:00 To 2022-07-31 00:00:00  

干预措施:

Interventions:

组别:

败血症组和对照组

样本量:

500

Group:

sepsis group and control group

Sample size:

干预措施:

干预措施代码:

Intervention:

no

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China 

Province:

Shanghai 

City:

 

单位(医院):

上海交通大学附属新华医院 

单位级别:

三甲医院 

Institution
hospital:

Xinhua Hospital affiliated to Shanghai Jiao Tong University School of Medicine

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

血脂代谢物

指标类型:

主要指标

Outcome:

lipid metabolism

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 1 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

N/A

Randomization Procedure (please state who generates the random number sequence and by what method):

N/A

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

待定

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not yet

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病史、治疗过程以及监测结果记录于资料表格中,每一个病例均有CRF表,于组长单位保存

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The medical history, treatment process and monitoring results are recorded in the data sheet. Each case has a CRF, which is stored in the leading center.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-08-13 12:23:14